X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Infection and Drug Resistance

期刊標題檢索 INFECT DRUG RES 最新評論: Will the revision be reviewed externally? (2024-05-13)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Infection and Drug Resistance]您好,您是該頁面的第 57639 位訪客。

期刊簡介
期刊名稱Infection and Drug Resistance Infection and Drug Resistance
LetPub Score
6.5
50 ratings
Rate

Reputation
7.2

Influence
5.3

Speed
9.0

期刊簡稱INFECT DRUG RESIST
ISSN1178-6973
h-index27
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.600.7430.947
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q288 / 272
Category: Medicine
Subcategory: Infectious Diseases
Q2126 / 344
Category: Medicine
Subcategory: Pharmacology
Q2134 / 313

自引率 (2023-2024)6.90%自引率趨勢
掲載範囲
About Journal
Editors
Peer Reviewers
Articles

Article Publishing Charges
Aims and Scope
Call For Papers

ISSN: 1178-6973

Editor-in-Chief: Professor Suresh Antony

An international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance.
官方網站https://www.dovepress.com/infection-and-drug-resistance-journal
在線稿件提交https://www.dovepress.com/submit_step_1.php
開放訪問Yes
出版商Dove Medical Press Ltd.
主題領域Medicine
出版國/地區UNITED STATES
發行頻率
創刊年0
每年文章數682每年文章數趨勢
黃金OA百分比98.64%
OA Related Info
APC: Yes( USD3300; )
APC waiver:Check Notes
Other charges: No
Keywords: bacterial infection、viral infection、fungal infection、antibiotic resistance、anti-infective drugs、infection control
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
INFECTIOUS DISEASESSCIEQ258/132
PHARMACOLOGY & PHARMACYSCIEQ2147/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1178-6973%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 16 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Infection and Drug Resistance】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    npj Breast CancerH-index: 0

    CiteScore: 10.10
    ACS Pharmacology & Translational ScienceH-index: 0

    CiteScore: 10.00
    Therapeutic Advances in Drug SafetyH-index: 0

    CiteScore: 6.70
    Translational and Clinical PharmacologyH-index: 0

    CiteScore: 1.60
    Medizinische Monatsschrift fur PharmazeutenH-index: 0

    CiteScore: 0.10
    Adverse Drug Reaction BulletinH-index: 0

    CiteScore: 0.70
    WHO Drug InformationH-index: 0

    CiteScore: 0.20
    Cancer and Chemotherapy ReviewsH-index: 0

    CiteScore: 0.10
    Journal fur Pharmakologie und TherapieH-index: 0

    CiteScore: 0.10
    P and TH-index: 0

    CiteScore: 7.60
    學科內最受檢索的期刊 頁面查看次數
    npj Breast Cancer15199
    ACS Pharmacology & Translational Science9761
    Therapeutic Advances in Drug Safety6552
    OpenNano3134
    Medicine in Drug Discovery2871
    WHO Drug Information2193
    P and T1782
    Cancer and Chemotherapy Reviews1592
    Medizinische Monatsschrift fur Pharmazeuten1537
    Journal fur Pharmakologie und Therapie1517
  •  

    Infection and Drug Resistance Infection and Drug Resistance
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [Infection and Drug Resistance] 的評論撰寫評論
作者:


領域:
審稿時間: 0.0 month(s)
結果:


撰寫評論

2024-10-13 10:17:59 評論於
 (0) 讚! |   

作者: 太山德本


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-13 17:12:49 評論於
Will the revision be reviewed externally?
(0) 讚! | 太山德本

作者: 太山德本


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-27 15:54:29 評論於
Is the revision rejected?
(0) 讚! | 太山德本

作者: Marsh Blake


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-19 09:06:13 評論於
Hello, how is your initial review going? It's been almost a month for me and I'm still in the initial review process
(0) 讚! | Marsh Blake

作者: 太山德本


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-08 16:56:37 評論於
Do you have a display for 2GX?
(0) 讚! | 太山德本

作者: 太山德本


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-08 10:05:49 評論於
Review speed: 4.0 | Submission hit rate: 50.0 Emphasized research direction: bioinformatics Sharing experience: Does 2GX represent a rejection?
(0) 讚! | 太山德本

作者: 江南谷菱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-02 16:03:59 評論於
It has been over a month for me
(0) 讚! | 江南谷菱

作者: 狒狒1


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-21 16:49:00 評論於
Do we need to edit this journal?
(0) 讚! | 狒狒1

作者: 巴蜀语柔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-04 22:51:58 評論於
What does submission status 1AB mean?
(0) 讚! | 巴蜀语柔

作者: 犬走鸿轩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-29 22:46:22 評論於
Is it still normal to be in the initial review after two weeks?
(0) 讚! | 犬走鸿轩

作者: 豆花❀


領域: 医学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2024-02-12 14:23:35 評論於
Submitted on November 20, 2023. Notice sent on January 31, 2024 for incomplete reviewers
(0) 讚! | 豆花❀

作者: 无极志行


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-13 12:49:32 評論於
How long does the external audit take?
(0) 讚! | 无极志行

作者: 东海浩旷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-02 18:40:15 評論於
How long did it take to find the reviewers?
(0) 讚! | 东海浩旷

作者: 振英mm


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-29 21:44:17 評論於
Review speed: 3.0 | Submission hit rate: 50.0
Experience sharing: Acceptance after two rounds of revisions, taking about 3 months from submission
(0) 讚! | 振英mm

作者: 悦人少女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-28 20:36:41 評論於
Review speed: 3.0 | Submission hit rate: 50.0 Emphasis on research direction: bioinformatics sharing experience: Was rejected after 3 months, found two reviewers, one gave good feedback, the other seemed to be a clinician. I used a machine learning model to predict a certain disease, the performance was very good, but he immediately said it was meaningless because clinical diagnosis should be based on imaging results. Without imaging, the selected indicators definitely cannot predict, etc. Really frustrated, if everything is included, doctors will diagnose it, there is significance in me doing this model...... Not understanding and not respecting. It's not an article within their own field, at least hope they can be quiet
(0) 讚! | 悦人少女

作者: 犬走鸿轩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-19 18:09:42 評論於
Hello, have you won?
(0) 讚! | 犬走鸿轩

作者: Sherry Louie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-12 19:34:26 評論於
Did you win?
(0) 讚! | Sherry Louie

作者: 犬走鸿轩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-07 11:50:59 評論於
I am so anxious
(0) 讚! | 犬走鸿轩

作者: 犬走鸿轩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-05 17:37:10 評論於
Hello, may I ask if your current status has changed?
(0) 讚! | 犬走鸿轩

作者: 璃月雅致


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-05 08:37:33 評論於
It has been 20 days and I have turned into 2D
(0) 讚! | 璃月雅致

作者: 璃月雅致


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-14 18:39:02 評論於
Research emphasis: sharing experiences of clinical infections: Is everyone else progressing quickly? Why has my status 2B (reviewer 1 approved the manuscript) been maintained for two weeks, causing me anxiety?
(0) 讚! | 璃月雅致

作者: 书生松奇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-04 19:23:03 評論於
Review speed: 2.0; Emphasized research field: Pharmaceutics; Experience sharing on drug resistance: Overall speed is fast, editors are nice, and layout fee is slightly high
(0) 讚! | 书生松奇

作者: 北风子默


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-30 09:26:55 評論於
Is ethical approval a requirement for submission? I have not submitted it yet
(0) 讚! | 北风子默

作者: 慕珊mio


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-17 11:30:26 評論於
7.13 submitted, unevaluated new submission after 3 weeks, peer review begins on 8.3, two or more peer reviewers assigned on 8.5, first report returned on 8.9, ethics approval and raw data uploaded on 8.10, then rejected by publisher on 8.11, reason being how informed consent was obtained from one-year-old children in retrospective analysis, total nonsense
(0) 讚! | 慕珊mio

作者: 是你的泰初呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-09 14:48:18 評論於
Did you win?
(0) 讚! | 是你的泰初呀

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [Infection and Drug Resistance] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*